MedTrace Logo

Daytime Sleepiness in Patients With the Assessment of a Sleep-related Respiratory Disorder

NCT04448470 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2020-06-25

No results posted yet for this study

Summary

It is not yet known whether an analysis of daytime sleepiness over the course of the day can predict the diagnosis or severity of sleep apnea. The goal of the study is to examine whether a psychometric determination of daytime sleepiness can adequately and practicably record daytime sleepiness in patients with mainly sleep apnea in comparison to other standardized methods.

Conditions

  • Sleep-related Respiratory Disorder

Interventions

OTHER

Questionnaire for recording daytime sleepiness over the course of the day

Questionnaire for recording daytime sleepiness over the course of the day

OTHER

Anamnesis and physicial examination

Anamnesis and physical examination, e.g. medication, comorbidities, complaints

OTHER

Questionnaire for quantifying daytime sleepiness

the Epworth Sleepiness Scale (ESS) questionnaire and the STOP BANG Questionnaire

DIAGNOSTIC_TEST

Pulmonary function test

The measured values of spirometry/body plethysmography, CO diffusion and blood gas analysis are documented, if available.

DIAGNOSTIC_TEST

Polygraphy

Polygraphy is a non-invasive portable examination method that the patient uses in the home environment at night to measure possible sleep-related breathing disorders. Typically, the following measurement signals are recorded: nasal airflow, thoracic and abdominal breathing excursions, snoring and breathing sounds via a microphone, pulse, oxygen saturation and position. The evaluation results and the findings are checked by a physician. Essential parameters include the apnoea-hypopnoea index, the number of obstructive, central and mixed apnoea/hypopnoea, the number and duration of desaturation, snoring or the association with a certain position.

Sponsors & Collaborators

  • Heinrich-Heine University, Duesseldorf

    lead OTHER

Principal Investigators

  • Malte Kelm, Prof. Dr. · Heinrich-Heine University, Duesseldorf

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-24
Primary Completion
2021-06-30
Completion
2021-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04448470 on ClinicalTrials.gov